Expression and purification of L-asparaginase from Escherichia coli and the inhibitory effects of cyclic dipeptides

References

• Azmi W, Narta UK, Kanwar SS. 2007. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol. 61:208–221.
   PubMed Web of Science ®Google Scholar
• Balcão VM, Mateo C, Fernández-Lafuente R, Malcata FX, Guisán JM. 2001. Coimmobilization of L-asparaginase and glutamate dehydrogenase onto highly activated supports. Enzyme Microb Technol. 28:696–704.10.1016/S0141-0229(01)00307-6
   PubMed Web of Science ®Google Scholar
• Becker FF, Broome JD. 1967. L-asparaginase: inhibition of early mitosis in regenerating rat liver. Science. 156:1602–1603.10.1126/science.156.3782.1602
   PubMed Web of Science ®Google Scholar
• Ben TM, Sharif-Askari B, Ceppi F, Laaribi H, Gagné V, Rousseau J, Labuda M, Silverman LB, Sallan SE, Neuberg D, et al. 2015. Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia. Clin Cancer Res. 21:329–334.
   PubMed Web of Science ®Google Scholar
• Benny PJ, Muraleedhara KG, Sreejith K, Jayashree G. 1996. Metabolism of proteins and glycoproteins in tumour bearing mice treated with Aeromonas L-asparaginase. Indian J Biochem Biophys. 33:30–527.
   PubMed Web of Science ®Google Scholar
• Broome JD. 1963. Evidence that the L-asparaginase activity of guineapig serum is responsible for its antilymphoma effect. J Exp Med. 118:99–120.10.1084/jem.118.1.99
   PubMed Web of Science ®Google Scholar
• Chandan P. 1995. Bioactive cyclic dipeptides. J Peptides. 16:151–164.
   PubMed Web of Science ®Google Scholar
• Cui CB, Kakeya H, Okada G, Onose R, Ubukata M, Takahashi I, Isono K, Osada H. 1995. Tryprostatins A and B, novel mammalian cell cycle inhibitors produced by Aspergillus fumigatus. J Antibiot (Tokyo). 48:1382–1384.10.7164/antibiotics.48.1382
   PubMed Web of Science ®Google Scholar
• El-Bessoumy AA, Sarhan M, Mansour J. 2004. Production, isolation, and purification of L-asparaginase from Pseudomonas aeruginosa 50071 using solid-state fermentation. BMB Rep. 37:387–393.10.5483/BMBRep.2004.37.4.387
   Web of Science ®Google Scholar
• Han S, Jung J, Park W. 2014. Biochemical characterization of L-asparaginase in NaCl-tolerant Staphylococcus sp. OJ82 isolated from fermented seafood. J Microbiol Biotechnol. 24:1096–1104.10.4014/jmb.1405.05021
   PubMed Web of Science ®Google Scholar
• Hong S, Moon BH, Yong Y, Shin SY, Lee YH, Lim Y. 2008. Inhibitory effect against Akt by cyclic dipeptides isolated from Bacillus sp. J Microbiol Biotechnol. 18:682–685.
   PubMed Web of Science ®Google Scholar
• Itai A, Yonei M, Mitsui Y, Itaka Y. 1976. Crystallographic study on the orthorhombic crystal of L-asparaginase from Escherichia coli HAP. J Mol Biol. 105:321–325.10.1016/0022-2836(76)90114-5
   PubMed Web of Science ®Google Scholar
• Keating MJ, Holmes R, Lerner S, Ho DH. 1993. L-asparaginase and PEG asparaginase – past, present, and future. 10:153–157.
   Google Scholar
• Kotzia GA, Labrou NE. 2011. Engineering substrate specificity of E. carotovora L-asparaginase for the development of biosensor. J Mol Catal B-Enzym. 72:95–101.10.1016/j.molcatb.2011.05.003
   Web of Science ®Google Scholar
• Krishnapura PR, Belur PD, Subramanya S. 2015. A critical review on properties and applications of microbial L-asparaginases. Crit Rev Microbiol. 13:1–18.10.3109/1040841X.2015.1022505
   Web of Science ®Google Scholar
• Kumar S, Venkata Dasu V, Pakshirajan K. 2011. Purification and characacterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428. Bioresour Technol. 102:2077–2082.10.1016/j.biortech.2010.07.114
   PubMed Web of Science ®Google Scholar
• Maita T, Morokuma K, Matsuda G. 1974. Amino acid sequence of L-asparaginase from Escherichia coli. J Biochem. 76:1351–1354.
   PubMed Web of Science ®Google Scholar
• Manna S, Sinha A, Sadhukhan R, Chakrabarty SL. 1995. Purification, characterization and antitumor activity of L-asparaginase isolated from Pseudomonas stutzeri MB-405. Curr Microb. 30:291–298.10.1007/BF00295504
   PubMed Web of Science ®Google Scholar
• Montero-Morán GM, Lara-González S, Álvarez-Añorve L, Plumbridge JA, Calcagno ML. 2001. On the multiple functional roles of the active site histidine in catalysis and allosteric regulation of Escherichia coli glucosamine 6-phosphate eaminase. Biochemistry. 40:10187–10196.10.1021/bi0105835
   PubMed Web of Science ®Google Scholar
• Müller HJ, Boos J. 1998. Use of L-asparaginase in childhood ALL. Crit Rev Oncol/Hematol. 28:97–113.10.1016/S1040-8428(98)00015-8
   PubMed Web of Science ®Google Scholar
• Nagarethinam S, Nagappa AN, Udupa N, Raa JV, Vanathi BM. 2012. Microbial L-asparaginase and its future prospects. Asian J Med Res. 1:159–168.
   Google Scholar
• Pession A, Valsecchi MG, Masera G, Kamps WA, Magyarosy E, Rizzari C, van Wering ER, Lo Nigro L, van der Does A, Locatelli F, et al. 2005. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. J Clin Oncol. 23:7161–7167.10.1200/JCO.2005.11.411
   PubMed Web of Science ®Google Scholar
• Pieters R, Hunger SP, Boos J, Rizzari C, Silverman L, Baruchel A, Goekbuget N, Schrappe M, Pui C-H. 2011. L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer. 117:238–249.10.1002/cncr.v117.2
   PubMed Web of Science ®Google Scholar
• Poznansky MJ, Shandling M, Salkie MA, Elliott JF, Lau E. 1982. Advantages in the use of L-asparaginase albumin polymer as antitumor agent. Cancer Res. 42:1020.
   PubMed Web of Science ®Google Scholar
• Shifrin S, Parrott CL. 1974. In vitro assembly of L-asparaginase subunits. J Biol Chem. 249:4175–4180.
   PubMed Web of Science ®Google Scholar
• Shrivastava A, Khan AA, Khurshid M, Kalam MA, Jain SK, Singhal PK. 2016. Recent developments in L-asparaginase discovery and its potential as anticancer agent. Crit Rev Oncol Hematol. 100:1–10.10.1016/j.critrevonc.2015.01.002
   PubMed Web of Science ®Google Scholar
• Ström K, Sjögren J, Broberg A, Schnürer J. 2002. Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid. Appl Environ Microbiol. 68:4322–4327.10.1128/AEM.68.9.4322-4327.2002
   PubMed Web of Science ®Google Scholar
• Verma N, Kumar K, Kaur G, Anand S. 2008. L-asparaginase: a promising chemotherapeutic agent. Crit Rev Biotechnol. 27:45–62.
   Web of Science ®Google Scholar
• Warangkar SC, Khobragade CN, Dawane BS, Bhosale RB. 2009. Effect of dihydropyrimidine derivatives on kinetic parameters of Erwinia carotovora L-asparaginase. Int J Biotechnol Appl. 1:5–13.
   Google Scholar
• Wu J, Wu WT, Lai LS, Liu JJ. 2004. Research of extraction process and properties of recombinant L-asparaginaseⅡ. J Chinese Pharmacy. 39:49–53.
   Google Scholar
• Yang ZJ, Xiang L, Xing J, Zheng Y. 2009. Research advances in cyclic dipeptides. J Modern Pharm Clin. 24:73–81.
   Google Scholar
• Yong W, Zheng W, Zhu J, Zhang Y, Wang X, Xie Y, Lin N, Xu B, Lu A, Li J. 2009. L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type. Annal Hematol. 88:647–652.10.1007/s00277-008-0669-3
   PubMed Web of Science ®Google Scholar
• Zuo S, Zhang T, Jiang B, Mu W. 2015. Recent research progress on microbial L-asparaginases. Appl Microbiol Biotechnol. 99:1069–1079.10.1007/s00253-014-6271-9
   PubMed Web of Science ®Google Scholar